Alpine Global Management’s Elevance Health ELV Stock Holding History

Alpine Global Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,763	Closed	-$1.77M	–	218
2023 Q4	$1.77M	Buy	+3,763	New	+$1.74M	0.48%	47
2020 Q3	–	Sell	-1,142	Closed	-$300K	–	303
2020 Q2	$300K	Buy	+1,142	New	+$305K	0.05%	210
2017 Q2	–	Sell	-1,463	Closed	-$242K	–	193
2017 Q1	$242K	Buy	+1,463	New	+$233K	0.06%	245
2015 Q3	–	Sell	-2,492	Closed	-$409K	–	312
2015 Q2	$409K	Sell	2,492 -1,770	-42%	-$283K	0.07%	211
2015 Q1	$658K	Sell	4,262 -1,657	-28%	-$236K	0.21%	106
2014 Q4	$744K	Buy	5,919 +2,109	+55%	+$261K	0.13%	172
2014 Q3	$456K	Buy	+3,810	New	+$437K	0.34%	67

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Alpine Global Management's ELV Position: Q1 2024 in Review

Alpine Global Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 3,763 shares — an estimated $1.77M sold.

Alpine Global Management first reported a position in ELV in Q3 2014 and held it in 7 quarters. The position peaked at $1.77M in Q4 2023. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Alpine Global Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
Alpine Global Management sold 3,763 Elevance Health shares in Q1 2024, an estimated $1.77M.
Alpine Global Management first reported a position in Elevance Health in Q3 2014 and held it in 7 quarters.
Alpine Global Management's Elevance Health position peaked at $1.77M in Q4 2023.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Alpine Global Management's 13F filing for Q1 2024, filed 15 May 2024.